Comparative localization of fibroblast growth factor receptor-1, -2, and -3 mRNAs in the rat brain: in situ hybridization analysis.
The present study provides a detailed comparative description in the adult rat brain of areas that express mRNAs coding for the fibroblast growth factor subtype receptors 1-3 (FGFR1-3). One observation in this analysis was a widespread expression in the brain of all three FGFR mRNAs, according to the following rank order: FGFR1, diencephalon < telencephalon < mesencephalon and metencephalon < myelencephalon; FGFR2 and FGFR3, telencephalon < diencephalon < mesencephalon and metencephalon < myelencephalon. Another observation was an apparent cellular specificity in their basal expression. Thus, the FGFR1 mRNA was expressed mainly in large and weakly stained cells, whereas FGFR2 transcripts were expressed primarily in small and strongly stained cells and in cells of brain regions devoid of neuronal cells, such as the white matter. FGFR3 mRNA was always detected in small and strongly stained cells with scattered distribution and was not expressed in the white matter. However, FGFR2 mRNA was weakly expressed also in large cells localized in some nuclei of the lower brainstem, in the diagonal band, and in the septum. Furthermore, in the medial habenula and in the nuclei of the pons, there exists a high density of cells expressing both FGFR1 and FGFR2 (60-100%). With neurotoxic lesions involving 6-hydroxydopamine microinjections in the substantia nigra, reactive glial cells in the lesioned area and surrounding the cannula tract showed an increase in the expression of both FGFR1 and FGFR2 mRNAs, whereas no increased expression was found for FGFR3 mRNA. Taken together, these findings showed that these three FGF receptors exist in all subtypes of cells of each brain region. Their apparent cellular specificity suggests that these receptor subtypes can have a differential trophic role in the brain, reflecting the various biological activities shown by the ligands of the FGF family.
Belluardo
N
N
Department of Neuroscience, Karolinska Institute, Stockholm, Sweden. Belluard@ictuniv.unict.it
Wu
G
G
Mudo
G
G
Hansson
A C
AC
Pettersson
R
R
Fuxe
K
K
D000818:Animals; D001345:Autoradiography; D001923:Brain Chemistry; D003714:Denervation; D004027:Diencephalon / Q000737:chemistry; D005346:Fibroblast Growth Factors / Q000235:genetics; D015870:Gene Expression / Q000502:physiology; D006801:Humans; D017403:In Situ Hybridization; D007231:Infant, Newborn; D008297:Male; D008526:Medulla Oblongata / Q000737:chemistry; D009339:Needles; D016627:Oxidopamine; D011149:Pons / Q000737:chemistry; D011505:Protein-Tyrosine Kinases; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley / Q000502:physiology*; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics; D051496:Receptor, Fibroblast Growth Factor, Type 1; D051497:Receptor, Fibroblast Growth Factor, Type 2; D051498:Receptor, Fibroblast Growth Factor, Type 3; D017468:Receptors, Fibroblast Growth Factor / Q000235:genetics*; D013378:Substantia Nigra / Q000737:chemistry / Q000293:injuries; D013565:Sympatholytics; D013687:Telencephalon / Q000737:chemistry; D014951:Wounds, Stab
D012333:RNA, Messenger; D017468:Receptors, Fibroblast Growth Factor; D013565:Sympatholytics; D005346:Fibroblast Growth Factors; D016627:Oxidopamine; C496348:FGFR1 protein, human; C496353:FGFR2 protein, human; C496365:FGFR3 protein, human; C496350:Fgfr1 protein, rat; C496356:Fgfr2 protein, rat; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases; D051496:Receptor, Fibroblast Growth Factor, Type 1; D051497:Receptor, Fibroblast Growth Factor, Type 2; D051498:Receptor, Fibroblast Growth Factor, Type 3